STRATEGY TO MINIMIZE THE BLEEDING RISKS IN PATIENTS WITH ATRIAL FIBRILLATION WHO RECEIVE COMBINED ANTITHROMBOTIC THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION

STRATEGY TO MINIMIZE THE BLEEDING RISKS IN PATIENTS WITH ATRIAL FIBRILLATION WHO RECEIVE COMBINED ANTITHROMBOTIC THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION

The use of combined antithrombotic therapy in patients with atrial fibrillation who underwent percutaneous coronary interventions is associated with an increased risk of bleeding. In this regard, minimizing haemorrhagic risk is one of the strategic priorities in the management of this clinical group...

Full description

Saved in:
Bibliographic Details
Main Author: D. A. Zateishchikov
Format: Article
Language:Russian
Published: «REMEDIUM GROUP» Ltd. 2018-05-01
Series:Атеротромбоз
Subjects:
atrial fibrillation
percutaneous coronary intervention
combined antithrombotic therapy
bleeding risk
dabigatran
rivaroxaban
apixaban
Online Access:https://www.aterotromboz.ru/jour/article/view/148
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items